Amryt Pharma agrees Lojuxta distribution deal for Romania and Bulgaria

By Andrew Scott / February 02, 2018 / www.proactiveinvestors.co.uk / Article Link

Dave Allmond, chief commercial officer at Amryt Pharma PLC (LON:AMYT), discusses with Proactive their fourth distribution deal signed in three months for Lojuxta.

Lojuxta treats a very rare, life-threatening genetic condition which causes "bad cholesterol" to accumulate in the body. 

This latest agreement, covering Romania and Bulgaria, is with Romastru Trading, part of the Pharaon Healthcare Europe conglomerate.

 Meet Anglo Asian Mining Plc, Condor Gold PLC, Connemara Mining and Papua Mining PLC at our event, London, 08 February 2018.Register here >>

Recent News

Mixed outlook for gold as it remains range bound for past three months

June 30, 2025 / www.canadianminingreport.com

Gold stocks down on flat metal price

June 30, 2025 / www.canadianminingreport.com

Gold stocks down on metal decline

June 23, 2025 / www.canadianminingreport.com

Huge quantifiable rise in geopolitical, economic and trade risks

June 23, 2025 / www.canadianminingreport.com

Platinum clearly ahead of palladium for first time in seven years

June 16, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok